MEDICAL IP, Multi-disease prediction and prevention AI solution unveiled at KCR 2021

MEDICAL IP participates in KCR 2021... Announces clinical research results using ‘DeepCatch'

▶ Presentation of research results on the prediction of multiple diseases such as metabolic syndrome and sarcopenia using ‘DeepCatch’

▶ Introduction of products such as X-ray quantification and treatment monitoring solution ‘TiSepX’ and 3D medical imaging technology

KCR 2021 MEDICAL IP Exhibition Booth

<2021-09-02> MEDICAL IP participated in the '77th Korean Congress of Radiology (KCR 2021)’ held from September 1 to September 4. At this event, innovative AI technologies, such as disease prediction and prevention solutions and treatment monitoring solutions, were introduced.

On the first day of the conference, Professor Nam-ki Hong from the Department of Endocrinology at Yonsei University Severance Hospital, as the first presenter at ‘AI Stage’ session, drew attention by announcing the clinical research results using MEDICAL IP's automatic medical image-based body composition analysis technology.

According to clinical results, DeepCatch's automatic AI body composition analysis technology can establish standard indicators of body composition for healthy people through CT big data.
Based on the results, it has been emphasized that DeepCatch can be used to predict and respond to risks, such as metabolic syndrome, sarcopenia, and osteoporosis.

AI Stage presentation by Professor Nam-ki Hong, Department of Endocrinology, Yonsei University Severance Hospital

Professor Hong Nam-ki said, “Changes in body composition, such as bones, muscles, and visceral fat, are factors that can determine chronic diseases related to aging. CT is data that can obtain quantitative information about body composition, and DeepCatch's AI technology, which analyzes body composition and calculates numerical information from CT, is useful for discovering body composition biomarkers and determining the possibility of multiple diseases including metabolic diseases. It will play a key role.”

Based on this differentiated technology, the demand for DeepCatch from medical staff and researchers who conduct CT analysis research is continuously increasing. With this KCR 2021 as an opportunity, more joint research and discussions on technology supply are expected.


Sep 15 / 2023

MEDICAL IP won the ‘Innovation Grand Prize’ at the <KHF Innovation Award>

Aug 31 / 2023

Changing the ‘Future of anatomy’ through MEDICAL IP's AI and digital twin technology

Aug 8 / 2023

MEDICAL IP, Selected as Gartner's Sample Vendor for 6 Consecutive Years


Questions on our public relations?

Ask us now.